Eli Lilly on Wednesday said its highly popular weight loss drug Zepbound showed the potential to treat patients with the most common sleep-related breathing disorder in two late-stage clinical trials. …
Continue Reading about Eli Lilly’s Weight Loss Drug Zepbound Shows Promise As A Sleep Apnea →